CytomX Therapeutics CTMX Noncash Deemed Dividend On Warrants
Noncash Deemed Dividend On Warrants at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept ctmx:NoncashDeemedDividendOnWarrants.
The official record: CytomX Therapeutics’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's noncash deemed dividend on warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CytomX Therapeutics's noncash deemed dividend on warrants?
- CytomX Therapeutics (CTMX) reported noncash deemed dividend on warrants of $750.5K in Q4 2025.
- What does noncash deemed dividend on warrants mean?
- This represents a non-cash accounting adjustment treated as a deemed dividend resulting from the modification or issuance of warrants. It reflects the economic impact of equity-linked instruments on the company's capital structure without an actual cash outflow. Investors monitor this to understand the impact of complex financial instruments on shareholder equity and earnings per share calculations.